Advertisement
Sunday, Nov 28, 2021
Outlook.com
Outlook.com

Johnson & Johnson Pauses COVID-19 Vaccine Trial After Participant Falls Ill

Johnson & Johnson has announced that one of it’s study participants is suffering from an ‘unexplained illness.’ The company has paused trials of its single dose COVID-19 vaccine.

Johnson & Johnson Pauses COVID-19 Vaccine Trial After Participant Falls Ill
Johnson & Johnson Pauses COVID-19 Vaccine Trial After Participant Falls Ill | Twitter
Johnson & Johnson Pauses COVID-19 Vaccine Trial After Participant Falls Ill
outlookindia.com
2020-10-13T09:16:01+05:30

Johnson & Johnson's COVID-19 vaccine trial has been paused while the company investigates whether a study participant's “unexplained illness” is related to the vaccine shot.
The company said in a statement on Monday evening that illnesses, accidents and other so-called adverse events “are an expected part of any clinical study, especially large studies,” but added that the company will set up a safety monitoring panel to determine the participant’s cause of illness. The company has said it will begin its investigation by first determining if the participant received the vaccine or a placebo. The company declined to reveal further details about the illness, citing the participant's privacy.

Temporary pauses in large medical studies are relatively common, however, the coronavirus vaccine has raised the stakes in these kinds of complications. Companies are required to investigate any serious or unexpected reaction that occurs during drug testing. Given that such tests are done on tens of thousands of people, some medical complications are expected.

Johnson & Johnson was aiming to enrol 60,000 volunteers to determine if its single-dose approach is safe and guarantees protection against coronavirus. Other COVID-19 vaccine candidates that are being developed in the US require two shots.

The final stage of testing of the COVID-19 vaccine candidate being developed by AstraZeneca and Oxford University has been paused in the US, as officials examine whether an illness in its trial poses a safety risk. That trial was stopped when a woman developed severe neurological symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, AstraZeneca said. However, the vaccine’s testing has resumed in other countries.

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Omicron: New Strain Of Coronavirus Escalates Need For Global Vaccine Sharing

Omicron: New Strain Of Coronavirus Escalates Need For Global Vaccine Sharing

'Despite the repeated warnings of health leaders, our failure to put vaccines into the arms of people in the developing world is now coming back to haunt us', wrote former British PM Gordon Brown.

Covid-19: Experts' Take On Omicron And Possibility Of Third Wave In India

Covid-19: Experts' Take On Omicron And Possibility Of Third Wave In India

Though the health experts and scientists in India have advised caution yet they feel that the current immune profile of the majority of the population in India makes them less vulnerable to Omicron as compared to any other country in the world.

IND Vs NZ, First Test, Day 4, Live: India 5 Wickets Down For 84

IND Vs NZ, First Test, Day 4, Live: India 5 Wickets Down For 84

The first India vs New Zealand Test is delicately poised with both teams having an opportunity to force a decision. Follow here live cricket scores and updates of IND vs NZ on Day 4.

What Is Omicron: All You Need To Know About The New Coronavirus Strain

What Is Omicron: All You Need To Know About The New Coronavirus Strain

After the detrimental Delta variant which took the world by storm in the second wave of Covid-19, WHO recently declared ‘Omicron’ as the latest ‘variant of concern’ (VOC).

Advertisement